Hepatitis G virus infection in patients transplanted for cryptogenic cirrhosis: Red flag or red herring?

Transplantation

Volumn 65, Issue 1, 1998, Pages 73-76

  Charlton, M R ^a   Brandhagen, D ^a   Wiesner, R H ^a   Gross Jr , J B ^a   Detmer, J ^b   Collins, M ^b   Kolberg, J ^b   Krom, R A F ^a   Persing, D H ^a  

^a MAYO CLINIC   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CRYPTOCOCCOSIS; FEMALE; HEPATITIS G VIRUS; HUMAN; HUMAN TISSUE; INFECTION RISK; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS HEPATITIS;

ADULT; DNA, VIRAL; FEMALE; FLAVIVIRIDAE; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE;

EID: 0031934987     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199801150-00014     Document Type: Article

References (24)

1. Kodali VP, Gordon SC, Silverman AL, McCray DG. Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitis. Am J Gastroenterol 1994; 89: 1836.
2. Belle SH, Beringer KC, Detre KM. An update of liver transplantation in the United States: recipient characteristics and outcome. In: Cecka JM, Terasaki PI, eds. Clinical Transplants 1995. Los Angeles: UCLA Tissue Typing Laboratory, 1996.
3. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362.
4. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease [Review]. Hepatology 1991; 14: 381.
5. Linnen J, Wages J Jr, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505.
6. Muerhoff AS, Leary TP, Simons JN, et al. Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis. J Virol 1995; 69: 5621.
7. De Felippi F, Romeo R, Rumi MG, Donato MF, Del Ninno E, Colombo M. Low prevalence of HGV-RNA in Italian patients with non-A-E chronic hepatitis [Abstract]. Hepatology 1996; 24: 499A.
8. Yamashita K, Oketani M, Oketani K, et al. Cryptogenic severe liver diseases in South Japan [Abstract]. Hepatology 1996; 24: 600A.
9. Hamid S, Jafri W, Khurshid M, et al. Hepaptitis G in the developing world: impact of HGV on liver disease in Pakistan [Abstract]. Hepatology 1996; 24: 520A.
10. Aikawa T, Sugai Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C [Letter]. N Engl J Med 1996; 334: 195.
11. Alter MJ, Gallagher M, Morris T, et al. Role of hepatitis G virus in the etiology and clinical course of viral hepatitis [Abstract]. Hepatology 1996; 24: 247A.
12. Belli L, Silini E, Alberti A, et al. HGV infection and liver transplantation: is HGV virus pathogenic? [Abstract]. Hepatology 1996; 24: 420A.
13. Hoofnagle JH, Lombardero M, Wei Y, Yun AJ, Kim JP. Hepatitis G virus (HGV) infection before and after liver transplantation for fulminant hepatic failure and cryptogenic cirrhosis [Abstract]. Hepatology 1996; 24: 189A.
14. Detmer J, Lagier R, Flynn J, et al. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J Clin Microbiol 1996; 34: 901.
15. Horn T, Chang CA, Collins ML. Hybridization properties of the 5′ methyl isocytidine/isoguanosine base pair in synthetic oligonucleotides. Tetrahedron Lett 1995; 36: 2033.
16. Collins ML, Zayati C, Detmer JJ, et al. Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. Anal Biochem 1995; 226: 120.
17. Masuko K, Mitsui T, Iwano K, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996; 334: 1485.
18. Alter HJ, Nakatsuji Y, Melpolder J, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336: 747.
19. Nubling CM, Lower J. GB-C genomes in a high-risk group, in plasma pools, and in intravenous immunoglobulin [Letter]. Lancet 1996; 347: 68.
20. Schmidt B, Korn K, Fleckenstein B. Molecular evidence for transmission of hepatitis G virus by blood transfusion [Letter]. Lancet 1996; 347: 909.
21. Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991; 13: 619.
22. Feray C, Gigou M, Samuel D, et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994; 20: 1137.
23. Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334: 815.
24. Balan V, Batts KP, Porayko MK, Krom RA, Ludwig J, Wiesner RH. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation. Hepatology 1993; 18: 1392.